— Know what they know.
Not Investment Advice

PTGX NASDAQ

Protagonist Therapeutics, Inc.
1W: -3.4% 1M: -3.4% 3M: +23.3% YTD: +17.0% 1Y: +118.9% 3Y: +301.6% 5Y: +234.8%
$99.19
-2.82 (-2.76%)
 
Weekly Expected Move ±6.0%
$90 $96 $102 $108 $114
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 41 · $6.4B mcap · 52M float · 1.43% daily turnover · Short 77% of daily vol

📊 Key Metrics

TTM
$74M
Revenue
-64.4% YoY
$-115M
Net Income
-304.1% YoY
$-116M
Free Cash Flow
-134.7% YoY
99.3%
Gross Margin
-6.5%
Op. Margin
6.7%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-17.8%
ROA-16.2%
ROIC-195.2%

Valuation

P/E-56.3
P/B9.8
EV/EBITDA-51.3

Leverage

Debt/Equity0.02
Current Ratio12.71
Interest Cov.0.0x

Quality Scores

Piotroski F1/9
Altman Z80.19
Beneish M-2.60

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms